Contingent valuation with an open-ended follow-up question: a test of scope effects
- PMID: 9466145
- DOI: 10.1002/(sici)1099-1050(199711)6:6<637::aid-hec314>3.0.co;2-v
Contingent valuation with an open-ended follow-up question: a test of scope effects
Abstract
It has been suggested that an open-ended follow-up question should be added to the binary contingent valuation question. Before this is generally recommended, it is important to evaluate the properties of such follow-up questions. Using a split sample approach, we test whether the open-ended follow-up is sensitive to the scope of the commodity being valued. No significant scope effects were detected. It is concluded that the results obtained do not support the use of an open-ended follow-up in contingent valuation applications.
Similar articles
-
Valuation of health changes with the contingent valuation method: a test of scope and question order effects.Health Econ. 1996 Nov-Dec;5(6):531-41. doi: 10.1002/(SICI)1099-1050(199611)5:6<531::AID-HEC235>3.0.CO;2-J. Health Econ. 1996. PMID: 9003940
-
Aiding priority setting in health care: is there a role for the contingent valuation method?Health Econ. 1997 Nov-Dec;6(6):603-12. doi: 10.1002/(sici)1099-1050(199711)6:6<603::aid-hec285>3.0.co;2-2. Health Econ. 1997. PMID: 9466142 Review.
-
Insensitivity to scope in contingent valuation studies: reason for dismissal of valuations?Appl Health Econ Health Policy. 2012 Nov 1;10(6):397-405. doi: 10.1007/BF03261874. Appl Health Econ Health Policy. 2012. PMID: 22963163
-
Construction of the contingent valuation market in health care: a critical assessment.Health Econ. 2003 Aug;12(8):609-28. doi: 10.1002/hec.755. Health Econ. 2003. PMID: 12898660 Review.
-
Empirical implications of response acquiescence in discrete-choice contingent valuation.Health Econ. 2006 Oct;15(10):1077-89. doi: 10.1002/hec.1107. Health Econ. 2006. PMID: 16518835 Clinical Trial.
Cited by
-
Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancy.Pharmacoeconomics. 2005;23(8):791-802. doi: 10.2165/00019053-200523080-00005. Pharmacoeconomics. 2005. PMID: 16097841
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources